Skip to main content

Site notifications

AusPAR: Ad26.COV2.S

Australian Public Assessment Report
Device/Product Name
COVID-19 Vaccine Janssen
Active ingredients
Ad26.COV2.S
AusPAR Date
Published
Submission Number
PM-2020-06173-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site